Thermo Fisher joins hands with IPH

BioSpectrum (India) - - SUPPLIER NEWS -

Thermo Fisher Sci­en­tific has signed an agree­ment with the In­sti­tute of Pathol­ogy Hei­del­berg (IPH) to es­tab­lish its Cen­ter of Molec­u­lar Pathol­ogy at Hei­del­berg Univer­sity Hos­pi­tal as the new­est mem­ber of the Next Gen­er­a­tion Se­quenc­ing Com­pan­ion Dx Cen­ter of Ex­cel­lence Pro­gram (COEP). The ini­tia­tive fo­cuses on forg­ing strate­gic col­lab­o­ra­tions with lead­ing, Euro­pean-based or­ga­ni­za­tions that can lead stud­ies us­ing Thermo Fisher’s On­comine port­fo­lio of re­search pan­els des­tined for de­vel­op­ment as com­pan­ion di­ag­nos­tics to help drive pre­ci­sion on­col­ogy in the re­gion. Work­ing in col­lab­o­ra­tion with phar­ma­ceu­ti­cal part­ners and Thermo Fisher, the IPH Cen­ter of Molec­u­lar Pathol­ogy, headed by Dr Al­brecht Sten­zinger, will con­duct stud­ies and clin­i­cal tri­als un­der the lead­er­ship of Prof Peter Schir­ma­cher, direc­tor of the In­sti­tute of Pathol­ogy of Hei­del­berg Univer­sity Hos­pi­tal. Leaders in their field, Dr Sten­zinger and his team have in-depth ex­per­tise with Thermo Fisher’s next-gen­er­a­tion se­quenc­ing (NGS) plat­forms and var­i­ous gene pan­els, which they use to pro­file in clin­i­cal tri­als across sev­eral cancer types and more than 3,500 sam­ples in clin­i­cal di­ag­nos­tics an­nu­ally.

The In­sti­tute is also the site of Ger­many’s largest tis­sue biobank, fea­tur­ing a so­phis­ti­cated lab­o­ra­tory in­for­ma­tion man­age­ment sys­tem that has in­cor­po­rated Thermo Fisher’s Ion Tor­rent bioin­for­mat­ics soft­ware. Cou­pled with its biomarker de­vel­op­ment and trans­la­tional di­ag­nos­tics pro­gram, the IPH is uniquely po­si­tioned as an ideal Thermo Fisher part­ner to de­velop NGS-based di­ag­nos­tics.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.